Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Latest News about DMT Recent news which mentions DMT Non-Hallucinogenic Psychedelic Treatment For Mental Health Disorders Shows Potential To Be Dosed Orally July 25, 2024 Tickers DMT ENVB NEWS Tags News Psychedelics mental health Psychedelics From Benzinga Divine Supply: How A California Church Became A Psychedelics And Weed Sanctuary Challenging Federal Prohibition May 06, 2024 Tickers DMT Tags Government DMT psilocybin mushrooms From Benzinga Next-Gen Psychedelics Companies SciSparc And Clearmind Collaboration File 3 Patents February 21, 2024 Tickers CMND CMND DMT NEWS Tags SPRC Psychedelics Benzinga From Benzinga DEA Raises THC, Psilocybin And DMT Production Quotas For Scientific Research Purposes January 02, 2024 Tickers DEA DMT MDMA NEWS Tags Cannabis Research marijuana research Government From Benzinga More Protocols And Guidance Are Needed As Momentum Builds For Veterans, Psychedelics, And Mental Health December 13, 2023 Tickers DMT MDMA Tags contributors DMT Veterans From Benzinga Psychedelics In Mexico: Are They Legal? Well, Yes And No December 10, 2023 Tickers DMT Tags General Ketamine Psychedelics From Benzinga Small Pharma's Q2 2024 Financial Highlights Ahead Of Cybin Merger For Global DMT Business October 20, 2023 Tickers CYBN DMT DMTTF Tags Markets Cannabis M&A From Benzinga The Fear Of Death Dissolved: How Psychedelic Trips And Near-Death Moments Change Our Outlook On Life's End August 17, 2023 Tickers DMT Tags General Ayahuasca Psychedelics From Benzinga How DMT Affects The Brain's Advanced Functions, Scientists Reveal The Truth April 29, 2023 Tickers DMT Tags contributors DMT Psychedelics From Benzinga Study Sheds Light On How A Brain On Ayahuasca's Psychedelic Component Looks March 24, 2023 Tickers DMT Tags Psychedelic/Assisted Therapies Global Markets From Benzinga DMT VS. Psilocybin: Are We All Experiencing The Same Trip? February 10, 2023 Tickers DMT Tags DMT contributors Benzinga From Benzinga Cybin Approved For First In-Human Dosing Of DMT Molecule CYB004, Milestone For Anxiety Disorder Treatment February 01, 2023 Tickers CYBN DMT Tags CYBN Doug Drysdale Benzinga From Benzinga Top 3 Psychedelic Storylines To Watch In 2023 January 29, 2023 Tickers ATAI CMPS DMT MDMA Tags CMPS Small Cap MDMA From Benzinga EXCLUSIVE: Defining 'Natural' Psychedelics, State Regulations & Ayahuasca's Benefits January 26, 2023 Tickers DMT FLHLF Tags Psychedelics Benzinga Small Cap From Benzinga A Psychedelic Program For Treatment Of Stroke: New Clinical Trial Begins Dosing January 18, 2023 Tickers AGNPF DMT Tags Psychedelics Benzinga Human Stroke From Benzinga Ayahuasca's Benefits Outweigh Risks, A New Australian Study Finds November 28, 2022 Tickers DMT Tags News Psychedelics Benzinga From Benzinga This Novel Short-Acting Psychedelic Compound Is Ready For First Phase 1 Clinical Try-Out October 31, 2022 Tickers DMT DMTTF Tags News DMTTF Penny Stocks From Benzinga A Foundational Study On Stroke Is Ready. Here Is Why It's Important September 12, 2022 Tickers AGNPF DMT Tags Management Legal Medical Research Ethics Committee From Benzinga DMT Producer PsyBio And Shrooms Grower Red Light Holland Share Their Most Recent Financial Results August 29, 2022 Tickers DMT PSYBF TRUFF Tags Retail Sales 5/MeO/DMT Management From Benzinga Science Feature: Next-Generation Psychedelics July 31, 2022 Tickers DMT Tags Markets Psilocybin Market News From Benzinga Encountering DMT Entities: Are They Real? June 23, 2022 Tickers DMT Tags Psychedelics Benzinga contributors From Benzinga A Deeper Look At DMT Trials & Studies June 14, 2022 Tickers DMT Tags Cannabis Market News Markets From Benzinga EXCLUSIVE: How Cybin Is Developing The Next Generation Of Psychedelics April 19, 2022 Tickers CYBN DMT PCC Tags Psychedelics Benzinga PCC22 From Benzinga Extending the Experience: Interview With DMT Pioneer Rick Strassman April 16, 2022 Tickers DMT Tags Cannabis Market News Markets From Benzinga Top 5 Most Influential Psychedelic Studies March 29, 2022 Tickers DMT MDMA Tags MDMA PTSD Psychedelics Research From Benzinga Forget Shrooms, Is Toad Venom The New Hallucinogenic Drug For The Rich And Famous? March 06, 2022 Tickers DMT Tags psychedelics Bufo toad venom From Benzinga DMT Vape Pen Patent Illustrates A Big Problem In The Psychedelics Industry February 14, 2022 Tickers DMT Tags Market News contributors DMT From Benzinga Inside A 5-MeO-DMT Retreat: Who Should And Shouldn't Embark On This 'Hero's Journey' February 12, 2022 Tickers DMT Tags Markets 5/MeO/DMT Market News From Benzinga Psychedelics Biotech Startup Launches Phase 1 Study On Ayahuasca's Active Ingredient February 03, 2022 Tickers DMT ENTBF Tags ENTBF Market News Cannabis From Benzinga Are Psychedelics Starting to Emerge as Legitimate Therapies? January 19, 2022 Tickers DMT MDMA Tags AdvisorShares Psychedelics ETF (PSIL) Ibogaine Atai Life Sciences From Stock Gumshoe Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.